Transgenic <i>Metarhizium</i> rapidly kills mosquitoes in a malaria-endemic region of Burkina Faso.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31147521.
- Also identified by DOI 10.1126/science.aaw8737.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria control efforts require implementation of new technologies that manage insecticide resistance. <i>Metarhizium pingshaense</i> provides an effective, mosquito-specific delivery system for potent insect-selective toxins. A semifield trial in a MosquitoSphere (a contained, near-natural environment) in Soumousso, a region of Burkina Faso where malaria is endemic, confirmed that the expression of an insect-specific toxin (Hybrid) increased fungal lethality and the likelihood that insecticide-resistant mosquitoes would be eliminated from a site. Also, as Hybrid-expressing <i>M. pingshaense</i> is effective at very low spore doses, its efficacy lasted longer than that of the unmodified <i>Metarhizium</i> Deployment of transgenic <i>Metarhizium</i> against mosquitoes could (subject to appropriate registration) be rapid, with products that could synergistically integrate with existing chemical control strategies to avert insecticide resistance.
Medical subject headings
- Culicidae
- Malaria
- Metarhizium
- Mosquito Control
- Spider Venoms